Anzahl der Einträge: 10.
2022
Weller, Johannes ,
Schäfer, Niklas,
Schaub, Christina,
Potthoff, Anna-Laura,
Steinbach, Joachim P.,
Schlegel, Uwe,
Sabel, Michael ,
Hau, Peter ,
Seidel, Clemens,
Krex, Dietmar,
Goldbrunner, Roland,
Pietsch, Torsten,
Tzaridis, Theophilos,
Zeyen, Thomas,
Borger, Valeri,
Güresir, Erdem,
Vatter, Hartmut,
Herrlinger, Ulrich und
Schneider, Matthias
(2022)
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.
Journal of Neuro-Oncology 159 (1), S. 95-101.
Zeyen, Thomas,
Potthoff, Anna-Laura,
Nemeth, Robert,
Heiland, Dieter H.,
Burger, Michael C.,
Steinbach, Joachim P.,
Hau, Peter,
Tabatabai, Ghazaleh,
Glas, Martin,
Schlegel, Uwe,
Grauer, Oliver,
Krex, Dietmar,
Schnell, Oliver,
Goldbrunner, Roland,
Sabel, Michael ,
Thon, Niklas,
Delev, Daniel,
Clusmann, Hans,
Seidel, Clemens,
Güresir, Erdem,
Schmid, Matthias ,
Schuss, Patrick ,
Giordano, Frank A.,
Radbruch, Alexander,
Becker, Albert,
Weller, Johannes,
Schaub, Christina,
Vatter, Hartmut,
Schilling, Judith,
Winkler, Frank ,
Herrlinger, Ulrich und
Schneider, Matthias
(2022)
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial.
Trials 23 (1).
Volltext nicht vorhanden.
2021
Hau, Peter ,
Frappaz, Didier,
Hovey, Elizabeth,
McCabe, Martin G. ,
Pajtler, Kristian W.,
Wiestler, Benedikt ,
Seidel, Clemens,
Combs, Stephanie E.,
Dirven, Linda,
Klein, Martin,
Anazodo, Antoinette ,
Hattingen, Elke ,
Hofer, Silvia,
Pfister, Stefan M. ,
Zimmer, Claus,
Kortmann, Rolf-Dieter,
Sunyach, Marie-Pierre,
Tanguy, Ronan,
Effeney, Rachel,
von Deimling, Andreas ,
Sahm, Felix ,
Rutkowski, Stefan,
Berghoff, Anna S.,
Franceschi, Enrico,
Pineda, Estela,
Beier, Dagmar ,
Peeters, Ellen,
Gorlia, Thierry,
Vanlancker, Maureen,
Bromberg, Jacoline E. C.,
Gautier, Julien,
Ziegler, David S. ,
Preusser, Matthias,
Wick, Wolfgang und
Weller, Michael
(2021)
Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23.
Cancers 13 (14), S. 3451.
Tzaridis, Theophilos ,
Schäfer, Niklas,
Weller, Johannes,
Steinbach, Joachim‐Peter,
Schlegel, Uwe,
Seidel, Sabine,
Sabel, Michael,
Hau, Peter,
Seidel, Clemens,
Krex, Dietmar,
Goldbrunner, Roland,
Tonn, Jörg‐Christian,
Grauer, Oliver,
Kebir, Sied,
Schneider, Matthias,
Schaub, Christina,
Vatter, Hartmut,
Coch, Christoph,
Glas, Martin,
Fimmers, Rolf,
Pietsch, Torsten,
Reifenberger, Guido,
Herrlinger, Ulrich und
Felsberg, Jörg
(2021)
MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial.
International Journal of Cancer 148 (7), S. 1695-1707.
Volltext nicht vorhanden.
Seidel, Clemens,
Heider, Sina,
Hau, Peter ,
Glasow, Annegret,
Dietzsch, Stefan und
Kortmann, Rolf-Dieter
(2021)
Radiotherapy in Medulloblastoma—Evolution of Treatment, Current Concepts and Future Perspectives.
Cancers 13 (23), S. 5945.
Volltext nicht vorhanden.
2020
Hau, Peter,
Dirven, Linda,
Luerding, Ralf,
Beier, Dagmar,
Bumes, Elisabeth,
Reinert, Christiane,
Seidel, Clemens,
Bonsanto, Matteo Mario,
Bremer, Michael,
Rieken, Stefan,
Combs, Stephanie E.,
Herrlinger, Ulrich,
Seliger, Corinna,
Kuntze, Holger,
Mayer‑Steinacker, Regine,
Dieing, Annette,
Bartels, Claudius,
Schnell, Oliver,
Weyerbrock, Astrid,
Seidel, Sabine,
Grauer, Oliver,
Nadji‑Ohl, Minou,
Paulsen, Frank ,
Weller, Michael und
Wick, Wolfgang
(2020)
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.
Journal of Neuro-Oncology 148, S. 117-130.
2019
Kebir, Sied,
Schaub, Christina,
Junold, Nina,
Hattingen, Elke ,
Schäfer, Niklas,
Steinbach, Joachim P.,
Weyerbrock, Astrid,
Hau, Peter,
Goldbrunner, Roland,
Galldiks, Norbert ,
Weller, Johannes ,
Mack, Frederic,
Tzaridis, Theophilos,
Bähr, Oliver,
Seidel, Clemens,
Schlegel, Uwe,
Schmidt-Graf, Friederike,
Rohde, Veit,
Borchers, Christian,
Tabatabai, Ghazaleh ,
Hänel, Mathias,
Sabel, Michael,
Gerlach, Rüdiger,
Krex, Dietmar,
Belka, Claus,
Vatter, Hartmut,
Proescholdt, Martin,
Glas, Martin und
Herrlinger, Ulrich
(2019)
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
Journal of Neuro-Oncology 144 (3), S. 501-509.
Volltext nicht vorhanden.
Weller, Johannes ,
Tzaridis, Theophilos,
Mack, Frederic,
Steinbach, Joachim Peter,
Schlegel, Uwe,
Hau, Peter,
Krex, Dietmar,
Grauer, Oliver,
Goldbrunner, Roland,
Bähr, Oliver,
Uhl, Martin,
Seidel, Clemens,
Tabatabai, Ghazaleh ,
Brehmer, Stefanie,
Bullinger, Lars,
Galldiks, Norbert ,
Schaub, Christina,
Kebir, Sied,
Stummer, Walter,
Simon, Matthias,
Fimmers, Rolf,
Coch, Christoph,
Glas, Martin,
Herrlinger, Ulrich und
Schäfer, Niklas
(2019)
Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
The Lancet Oncology 20 (10), S. 1444-1453.
Volltext nicht vorhanden.
Herrlinger, Ulrich,
Tzaridis, Theophilos,
Mack, Frederic,
Steinbach, Joachim Peter,
Schlegel, Uwe,
Sabel, Michael,
Hau, Peter ,
Kortmann, Rolf-Dieter,
Krex, Dietmar,
Grauer, Oliver,
Goldbrunner, Roland,
Schnell, Oliver,
Bähr, Oliver,
Uhl, Martin,
Seidel, Clemens,
Tabatabai, Ghazaleh ,
Kowalski, Thomas,
Ringel, Florian,
Schmidt-Graf, Friederike,
Suchorska, Bogdana,
Brehmer, Stefanie,
Weyerbrock, Astrid,
Renovanz, Miriam,
Bullinger, Lars,
Galldiks, Norbert ,
Vajkoczy, Peter,
Misch, Martin,
Vatter, Hartmut,
Stuplich, Moritz,
Schäfer, Niklas,
Kebir, Sied,
Weller, Johannes ,
Schaub, Christina,
Stummer, Walter,
Tonn, Jörg-Christian,
Simon, Matthias,
Keil, Vera C.,
Nelles, Michael,
Urbach, Horst,
Coenen, Martin,
Wick, Wolfgang ,
Weller, Michael ,
Fimmers, Rolf,
Schmid, Matthias ,
Hattingen, Elke ,
Pietsch, Torsten,
Coch, Christoph und
Glas, Martin
(2019)
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial.
The Lancet 393 (10172), S. 678-688.
Volltext nicht vorhanden.
2017
Beier, Dagmar,
Proescholdt, Martin,
Reinert, Christiane,
Pietsch, Torsten,
Jones, David T W ,
Pfister, Stefan M ,
Hattingen, Elke ,
Seidel, Clemens,
Dirven, Linda,
Luerding, Ralf,
Reijneveld, Jaap,
Warmuth-Metz, Monika,
Bonsanto, Matteo,
Bremer, Michael,
Combs, Stephanie E,
Rieken, Stefan,
Herrlinger, Ulrich,
Kuntze, Holger,
Mayer-Steinacker, Regine,
Moskopp, Dag,
Schneider, Thomas,
Beringer, Andreas,
Schlegel, Uwe,
Stummer, Walter,
Welker, Helmut,
Weyerbrock, Astrid,
Paulsen, Frank,
Rutkowski, Stefan,
Weller, Michael,
Wick, Wolfgang,
Kortmann, Rolf-Dieter,
Bogdahn, Ulrich und
Hau, Peter
(2017)
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
Neuro-Oncology 20 (3), S. 400-410.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Sat Apr 27 05:12:03 2024 CEST.